Concert Genetics
An experienced operations executive, Dan has a passion for digitizing and streamlining genetic test selection, ordering, billing, and payment to enable high-quality, cost-effective precision medicine. At Concert, Dan focuses on delivering operational efficiency inside and outside the organization, including customer implementations, project management and process improvement.
Recent successful implementations include hub-and-spoke model interfacing between health system EHRs and genetic reference laboratory LIS platforms, incorporating structural variant data in interface exchanges, and implementing real-time claims payment accuracy solutions for health plan customers.
Dan has almost 20 years of healthcare experience in areas ranging from pharmaceutical clinical trial management to diagnostic laboratory operations. In Dan’s previous role as Marketing Manager for a leading academic genetic testing laboratory, Dan directed marketing and business development operations including leading an organization-wide rebranding effort and overseeing the sales and client relations for the lab. Dan earned his undergraduate degree from Lafayette College, and his MBA from Emory University’s Goizueta Business School with a focus in marketing and strategy.
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.